Search Results

A new era of science at the Advanced Photon Source is ready to begin. On June 17, 2024, the facility at the U.S. Department of Energy’s Argonne National Laboratory delivered its first X-ray light beams to a scientific beamline as part of a comprehensive and complex upgrade.

Rafa Laboratories, LTD., a leading manufacturer of Emergency Medical Solutions, and the Biomedical Advanced Research and Development Authority, part of the Administration for Strategic Preparedness and Response at the U.S. Department of Health and Human Services, aim to enhance the national preparedness for nerve agent emergencies by developing a new design for Rafa’s pediatric atropine autoinjectors.

bioLytical Laboratories Inc. proudly announces its donation of 1,200 INSTI® HIV-1/2 Antibody Tests to KFF’s Greater Than AIDS campaign in support of National HIV Testing Day, June 27.

ARUP Laboratories today released the company’s public comment on the FDA’s proposed rule to regulate laboratory-developed tests (LDTs) as medical devices, urging the agency to withdraw the rule.

HealthTrackRx, the nation’s premier molecular diagnostic testing laboratory, announced the opening of its latest high-throughput lab in Los Angeles, CA.

The U.S. Department of Energy’s Argonne National Laboratory is a founding partner of Duality, the first program in the nation that is dedicated to accelerating startup companies focused on quantum science and technology — a rapidly emerging area that is poised to drive transformative advances across multiple industries.

Xact Laboratories LLC (Xact) is excited to announce a groundbreaking partnership with a national prescription claims clearinghouse (commonly known as a “Switch”), to automate the integration of cutting-edge pharmacogenomic testing results to aid providers in optimizing prescription medical therapy for members from participating health plans.

C2N Diagnostics, LLC, which provides exceptional clinical laboratory services and advanced diagnostic solutions in the field of brain health, has entered into a non-exclusive agreement with Mayo Clinic Laboratories, for inclusion of C2N’s Precivity tests in Mayo Clinic Laboratories’ test offerings to its clients.